Skip to Main Content

Practical Implications of Executive Orders to Lower Costs for Prescription Drugs

This Briefing is brought to you by AHLA’s Payers, Plans, and Managed Care Practice Group.
  • October 05, 2020
  • Jen McDowell , Chicago, IL

On July 24, 2020, President Trump issued a series of four Executive Orders intended to lower the cost of prescription drugs for Americans. Three of the four Executive Orders were published in the Federal Register shortly after issuance:

The fourth Executive Order, numbered 13947 and governing costs for Medicare Part B drugs, was initially withheld from publication in an attempt to prompt legislative action from Congress or voluntary price concessions from pharmaceutical manufacturers. Nearly two months after Executive Order 13947 was announced, and with no action taken in response to the President’s directive, a new Executive Order 13948 on Lowering Drug Prices by Putting America First, was issued on September 13, 2020.

You must be logged in to access this content.